The data displays a ranking of the top 10 best-selling biotech drugs worldwide in 2015. In that year, Amgen's Enbrel generated a revenue of some 5.36 billion USD, and thus was the world's eighth biotech drug based on revenue.
Best-selling biotech drugs worldwide
AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 14.01 billion USD and 7.33 billion USD, respectively, in 2015. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin.
